NCT00548002

Combination Therapy With Fluoroquinolone in Staphylococcus Aureus Bacteremia

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 430 (actual)
• Sponsor: University of Helsinki · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To study whether fluoroquinolone (trovafloxacin or levofloxacin), added to standard treatment, could reduce the high mortality and complication rates in Staphylococcus aureus bacteremia.

Conditions

• Staphylococcus Aureus
• Bacteremia
• Endocarditis
• Sepsis

Interventions

Type	Name	Description
DRUG	trovafloxacin and levofloxacin	Trovafloxacin: \<60 kg 200 mg iv/orally once daily and \>60 kg 300 mg iv/orally once daily Levofloxacin: \< 60 kg 500 mg iv/orally once daily and \>60 kg 500 mg iv/orally bid

Timeline

• Start date: 1999-01-01
• Completion: 2002-08-01
• First posted: 2007-10-23
• Last updated: 2007-10-23

Locations

1 site across 1 country: Finland